Literature DB >> 12444303

A novel assay to measure the calcium flux in human basophils: effects of chemokines and nerve growth factor.

Akos Heinemann1, Martina Ofner, Rainer Amann, Bernhard A Peskar.   

Abstract

The calcium flux in human basophils was measured by flow cytometry. Peripheral blood mononuclear cells were labeled with anti-CD123 and anti-HLA-DR antibodies, loaded with fluo-3 acetoxymethyl ester (2 micromol/l) in the presence of probenecid (2.5 micromol/l) and Pluronic F-127 (0.02%) for 20 min, and equilibrated with Ca(2+) (1.8 mmol/l) and Mg(2+) (1 mmol/l) for 5 min. The levels of intracellular free calcium were monitored as changes in fluorescence. Cross-linking of surface IgE on basophils with anti-IgE antibodies caused effective calcium flux in atopic, but not in healthy, donors. Concentration-dependent responses to monocyte chemoattractant protein 1 (MCP-1), eotaxin, macrophage inflammatory protein 1 alpha (MIP-1alpha), and C5a (0.3-10 nmol/l) were observed in all subjects, with a rank order of potency of C5a = MCP-1 > eotaxin > MIP-1alpha. In contrast, the rank order of potency in causing basophil shape change (i.e., increase in forward scatter) was eotaxin > C5a > MCP-1 > MIP-1alpha. Nerve growth factor (NGF; 15 nmol/l) did not induce calcium flux in basophils, and pretreatment of cells with a low concentration of NGF (0.3 nmol/l), which has previously been shown to prime basophils for mediator release, had no effect on the calcium response to subsequent stimulation with C5a. We conclude that calcium mobilization is differentially involved in signaling to chemoattractants in basophils and that it is correlated with the agonist's efficacy to induce mediator release. The data also suggest that priming of basophil responses by NGF does not rely on enhanced calcium mobilization. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12444303     DOI: 10.1159/000066786

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  6 in total

1.  EP4 receptor stimulation down-regulates human eosinophil function.

Authors:  Petra Luschnig-Schratl; Eva M Sturm; Viktoria Konya; Sonia Philipose; Gunther Marsche; Eleonore Fröhlich; Claudia Samberger; Doris Lang-Loidolt; Stefan Gattenlöhner; Irmgard Th Lippe; Bernhard A Peskar; Rufina Schuligoi; Akos Heinemann
Journal:  Cell Mol Life Sci       Date:  2011-03-02       Impact factor: 9.261

2.  Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL.

Authors:  Sanja Curcic; Michael Holzer; Robert Frei; Lisa Pasterk; Rudolf Schicho; Akos Heinemann; Gunther Marsche
Journal:  Biochim Biophys Acta       Date:  2014-11-24

3.  Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation.

Authors:  Sonia Philipose; Viktoria Konya; Mirjana Lazarevic; Lisa M Pasterk; Gunther Marsche; Sasa Frank; Bernhard A Peskar; Akos Heinemann; Rufina Schuligoi
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

4.  Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen-induced pulmonary inflammation in mice.

Authors:  R B Frei; P Luschnig; G P Parzmair; M Peinhaupt; S Schranz; A Fauland; C E Wheelock; A Heinemann; E M Sturm
Journal:  Allergy       Date:  2016-03-16       Impact factor: 13.146

5.  Flux change in basophil membrane is not the main pathogenesis for hypersensitivity.

Authors:  Viroj Wiwanitkit
Journal:  Int J Nanomedicine       Date:  2007

6.  The anti-parasitic drug miltefosine suppresses activation of human eosinophils and ameliorates allergic inflammation in mice.

Authors:  Eva Knuplez; Melanie Kienzl; Athina Trakaki; Rudolf Schicho; Akos Heinemann; Eva M Sturm; Gunther Marsche
Journal:  Br J Pharmacol       Date:  2021-02-02       Impact factor: 9.473

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.